Xanthohumol Is a Potent Pan-Inhibitor of Coronaviruses Targeting Main Protease.
Int J Mol Sci
; 22(22)2021 Nov 09.
Статья
в английский
| MEDLINE | ID: covidwho-1512384
ABSTRACT
Coronaviruses cause diseases in humans and livestock. The SARS-CoV-2 is infecting millions of human beings, with high morbidity and mortality worldwide. The main protease (Mpro) of coronavirus plays a pivotal role in viral replication and transcription, which, in theory, is an attractive drug target for antiviral drug development. It has been extensively discussed whether Xanthohumol is able to help COVID-19 patients. Here, we report that Xanthohumol, a small molecule in clinical trials from hops (Humulus lupulus), was a potent pan-inhibitor for various coronaviruses by targeting Mpro, for example, betacoronavirus SARS-CoV-2 (IC50 value of 1.53 µM), and alphacoronavirus PEDV (IC50 value of 7.51 µM). Xanthohumol inhibited Mpro activities in the enzymatical assays, while pretreatment with Xanthohumol restricted the SARS-CoV-2 and PEDV replication in Vero-E6 cells. Therefore, Xanthohumol is a potent pan-inhibitor of coronaviruses and an excellent lead compound for further drug development.
ключевые слова
Полный текст:
Имеется в наличии
Коллекция:
Международные базы данных
база данных:
MEDLINE
Основная тема:
Propiophenones
/
Protease Inhibitors
/
Flavonoids
/
3C Viral Proteases
/
SARS-CoV-2
Тип исследования:
Прогностическое исследование
Язык:
английский
Год:
2021
Тип:
Статья
Аффилированная страна:
Ijms222212134
Документы, близкие по теме
MEDLINE
...
LILACS
LIS